Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2278-2284
Published online before print May 8, 2006, doi: 10.1161/CIRCULATIONAHA.105.607333
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/19/2278    most recent
CIRCULATIONAHA.105.607333v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Healy, A. M.
Right arrow Articles by Simon, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, A. M.
Right arrow Articles by Simon, D. I.
Related Collections
Right arrow Pathophysiology
Right arrow Functional genomics
Right arrow Gene expression
Right arrow Acute myocardial infarction
Right arrow Platelets

(Circulation. 2006;113:2278-2284.)
© 2006 American Heart Association, Inc.


Coronary Heart Disease

Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events

Aileen M. Healy, PhD; Michael D. Pickard, MA; Aruna D. Pradhan, MD; Yunmei Wang, PhD; Zhiping Chen, MS; Kevin Croce, MD, PhD; Masashi Sakuma, MD; Can Shi, PhD; Alexandre C. Zago, MD; Joseph Garasic, MD; Andrew I. Damokosh, PhD; Tracy L. Dowie, BS; Louis Poisson, MS; James Lillie, PhD; Peter Libby, MD; Paul M Ridker, MD; Daniel I. Simon, MD

From Millennium Pharmaceuticals, Inc (A.M.H., M.D.P., A.I.D., T.L.D., L.P., J.L.), Cambridge, Mass; Cardiovascular Division (A.D.P., Y.W., Z.C., K.C., M.S., C.S., A.C.Z., P.L., P.M.R., D.I.S.), the Center for Cardiovascular Disease Prevention (A.D.P., P.M.R.), and Donald W. Reynolds Center for Clinical Cardiovascular Research (A.D.P., P.L., P.M.R.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and Cardiology Division (J.G.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Daniel I. Simon, MD, Brigham and Women’s Hospital, 75 Francis St, PBB-1, Boston, MA 02115. E-mail dsimon{at}rics.bwh.harvard.edu

Received December 9, 2005; revision received March 17, 2006; accepted March 20, 2006.

Background— Platelets participate in events that immediately precede acute myocardial infarction. Because platelets lack nuclear DNA but retain megakaryocyte-derived mRNAs, the platelet transcriptome provides a novel window on gene expression preceding acute coronary events.

Methods and Results— We profiled platelet mRNA from patients with acute ST-segment–elevation myocardial infarction (STEMI, n=16) or stable coronary artery disease (n=44). The platelet transcriptomes were analyzed and single-gene models constructed to identify candidate genes with differential expression. We validated 1 candidate gene product by performing a prospective, nested case-control study (n=255 case-control pairs) among apparently healthy women to assess the risk of future cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death) associated with baseline plasma levels of the candidate protein. Platelets isolated from STEMI and coronary artery disease patients contained 54 differentially expressed transcripts. The strongest discriminators of STEMI in the microarrays were CD69 (odds ratio 6.2, P<0.001) and myeloid-related protein-14 (MRP-14; odds ratio 3.3, P=0.002). Plasma levels of MRP-8/14 heterodimer were higher in STEMI patients (17.0 versus 8.0 µg/mL, P<0.001). In the validation study, the risk of a first cardiovascular event increased with each increasing quartile of MRP-8/14 (Ptrend<0.001) such that women with the highest levels had a 3.8-fold increase in risk of any vascular event (P<0.001). Risks were independent of standard risk factors and C-reactive protein.

Conclusions— The platelet transcriptome reveals quantitative differences between acute and stable coronary artery disease. MRP-14 expression increases before STEMI, and increasing plasma concentrations of MRP-8/14 among healthy individuals predict the risk of future cardiovascular events.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. Y. Lim, M. J. Raftery, J. Goyette, K. Hsu, and C. L. Geczy
Oxidative modifications of S100 proteins: functional regulation by redox
J. Leukoc. Biol., September 1, 2009; 86(3): 577 - 587.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. M. Ehrchen, C. Sunderkotter, D. Foell, T. Vogl, and J. Roth
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
J. Leukoc. Biol., September 1, 2009; 86(3): 557 - 566.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Croce, H. Gao, Y. Wang, T. Mooroka, M. Sakuma, C. Shi, G. K. Sukhova, R. R.S. Packard, N. Hogg, P. Libby, et al.
Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
Circulation, August 4, 2009; 120(5): 427 - 436.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. G. Ionita, A. Vink, I. E. Dijke, J. D. Laman, W. Peeters, P. H. van der Kraak, F. L. Moll, J.-P. P.M. de Vries, G. Pasterkamp, and D. P.V. de Kleijn
High Levels of Myeloid-Related Protein 14 in Human Atherosclerotic Plaques Correlate With the Characteristics of Rupture-Prone Lesions
Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1220 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Goyette, W. X. Yan, E. Yamen, Y. M. Chung, S. Y. Lim, K. Hsu, F. Rahimi, N. Di Girolamo, C. Song, W. Jessup, et al.
Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture
J. Immunol., July 1, 2009; 183(1): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. A. Bozza, A. M. Shah, A. S. Weyrich, and G. A. Zimmerman
Amicus or Adversary: Platelets in Lung Biology, Acute Injury, and Inflammation
Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 123 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. D. Lamon and D. P. Hajjar
Inflammation at the Molecular Interface of Atherogenesis: An Anthropological Journey
Am. J. Pathol., November 1, 2008; 173(5): 1253 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jayachandran, R. D. Litwiller, W. G. Owen, J. A. Heit, T. Behrenbeck, S. L. Mulvagh, P. A. Araoz, M. J. Budoff, S. M. Harman, and V. M. Miller
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H931 - H938.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Miyamoto, M Ueda, M Ikemoto, T Naruko, A Itoh, S Tamaki, R Nohara, F Terasaki, S Sasayama, and M Fujita
Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina
Heart, August 1, 2008; 94(8): 1002 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Brambilla, M. Camera, D. Colnago, G. Marenzi, M. De Metrio, P. L. Giesen, A. Balduini, F. Veglia, K. Gertow, P. Biglioli, et al.
Tissue Factor in Patients With Acute Coronary Syndromes: Expression in Platelets, Leukocytes, and Platelet-Leukocyte Aggregates
Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 947 - 953.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. A. Zimmerman and A. S. Weyrich
Signal-Dependent Protein Synthesis by Activated Platelets: New Pathways to Altered Phenotype and Function
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s17 - s24.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Johansson, F. Kramer, S. Barnhart, J. E. Kanter, T. Vaisar, R. D. Merrill, L. Geng, K. Oka, L. Chan, A. Chait, et al.
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
PNAS, February 12, 2008; 105(6): 2082 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. R. S. Packard and P. Libby
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Clin. Chem., January 1, 2008; 54(1): 24 - 38.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Davi and C. Patrono
Platelet Activation and Atherothrombosis
N. Engl. J. Med., December 13, 2007; 357(24): 2482 - 2494.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. C. Becker
Emerging Paradigms, Platforms, and Unifying Themes in Biomarker Science
J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1777 - 1780.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. T. Miller, P. M. Ridker, P. Libby, and D. J. Kwiatkowski
Atherosclerosis: The Path From Genomics to Therapeutics
J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1589 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. A. Altwegg, M. Neidhart, M. Hersberger, S. Muller, F. R. Eberli, R. Corti, M. Roffi, G. Sutsch, S. Gay, A. von Eckardstein, et al.
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes
Eur. Heart J., April 12, 2007; (2007) ehm078v3.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Raghavachari, X. Xu, A. Harris, J. Villagra, C. Logun, J. Barb, M. A. Solomon, A. F. Suffredini, R. L. Danner, G. Kato, et al.
Amplified Expression Profiling of Platelet Transcriptome Reveals Changes in Arginine Metabolic Pathways in Patients With Sickle Cell Disease
Circulation, March 27, 2007; 115(12): 1551 - 1562.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Krishnan, A. H. Goodall, and P. Bugert
Letter by Krishnan et al Regarding Article, "Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events"
Circulation, February 13, 2007; 115(6): e186 - e186.
[Full Text] [PDF]


Home page
CirculationHome page
A. M. Healy, M. D. Pickard, A. I. Damokosh, T. L. Dowie, L. Poisson, J. Lillie, A. D. Pradhan, P. Libby, P. M Ridker, Y. Wang, et al.
Response to Letter Regarding Article, "Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events"
Circulation, February 13, 2007; 115(6): e187 - e187.
[Full Text] [PDF]